Clinical Trial Update: Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing weight changes in stable schizophrenia patients treated with bifeprunox versus quetiapine has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Bifeprunox (bifeprunox)
• Quetiapine (quetiapine)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Schizophrenia | Phase 3 | Status: TERMINATED